Legal Opinion
Schering Corp. v. Amgen, Inc.
District Court, D. Delaware
Decided July 30, 1998No. CIV.A. 96-587 MMSPublishedCited by 7 opinions
1Opinion of the Court
OPINION
MURRAY M. SCHWARTZ, Senior District Judge.
I. Introduction
Schering Corporation (“Schering”) and Biogen, Inc. (“Biogen”) (collectively “Scher-ing”) filed a patent infringement suit against Amgen, Inc. (“Amgen”), alleging Amgen infringed Biogen’s U.S. Patent No. 4,530,901 (“the ’901 Patent”), entitled “Recombinant DNA Molecules and Their Use in Producing Human Interferon-Like Polypeptides.” 1 Amgen answered the Complaint alleging various affirmative defenses and counterclaimed seeking a declaratory judgment that the ’901 Patent is unenforceable, invalid, not infringed, and has been…
2Cases cited59 opinions
- Allen v. McCurrySupreme Court of the United States · 1980
- Parklane Hosiery Co. v. ShoreSupreme Court of the United States · 1979
- Montana v. United StatesSupreme Court of the United States · 1979
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Herbert Markman and Positek, Inc. v. Westview Instruments, Inc. And Althon Enterprises, Inc.Court of Appeals for the Federal Circuit · 1995
54 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- Schering Corporation and Biogen, Inc. v. Amgen Inc.Court of Appeals for the Federal Circuit · 2000
- Schering Corp. v. Amgen, Inc.District Court, D. Delaware · 1998
- Exxon Research & Engineering Co. v. United StatesUnited States Court of Federal Claims · 2000
- Relume Corp. v. Dialight Corp.District Court, E.D. Michigan · 1999
- Schering Corp. v. Amgen, Inc.District Court, D. Delaware · 1999
2 more not listed; retrieve them via the Exa API.